Oral phosphate binding agents have been used for the treatment of hyperphosphatemia in dialysis patients for decades. Their safety record was marred in the early 1980's by reports of aluminium-related ...
Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Aluminum Sodium Phosphate (CAS 7785-88-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" has been added to ...
Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Aluminum Phosphate (CAS 98499-64-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" has been added to ...
The problem of phosphate accumulation became apparent quite early in the history of dialysis. Soft tissue and vascular calcification could often be clearly visualised on plain x-ray because of calcium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results